Rhythm Pharmaceuticals, Inc.
RYTM
शेयरों में रैंक
#2975
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial... Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or the leptin receptor (LEPR), alongside its use in patients with Bardet-Biedl and Alström syndromes. Furthermore, the company is progressing setmelanotide (the active compound in IMCIVREE) through Phase II clinical trials. These studies are evaluating its potential for a broader spectrum of applications, including obesity caused by heterozygous POMC or LEPR deficiencies, steroid receptor coactivator 1 (SRC1) deficiency, SH2B1 deficiency, MC4 receptor deficiency, and obesity associated with Smith-Magenis syndrome, POMC epigenetic disorders, and other MC4R-related conditions. Rhythm Pharmaceuticals holds a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The firm, headquartered in Boston, Massachusetts, was established in 2008 and changed its name from Rhythm Metabolic, Inc. to Rhythm Pharmaceuticals, Inc. in October 2015.
शेयर मूल्य
$88.46
अंतिम समन्वयन: 2026-10-21
मार्केट कैप
$6.09B
बदलाव (1 दिन)
-1.93%
बदलाव (1 वर्ष)
-18.97%
देश
US
व्यापार Rhythm Pharmaceuticals, Inc. (RYTM)
श्रेणी
Healthcare
Rhythm Pharmaceuticals, Inc. (RYTM) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $89.50 (2026-10-01 को)
दिन का सबसे निम्न समापन मूल्य: $24.67 (2017-10-01 को)
दिन का सबसे निम्न समापन मूल्य: $24.67 (2017-10-01 को)
Rhythm Pharmaceuticals, Inc. के स्टॉक मूल्य का इतिहास 2017 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
| वर्ष | प्रदर्शन |
|---|---|
| 2026 (TTM) | -8.88% |
| 2025 | 91.54% |
| 2024 | 34.76% |
| 2023 | 48.81% |
| 2022 | 174.77% |
| 2021 | -64.82% |
| 2020 | 24.27% |
| 2019 | -12.59% |
| 2018 | -6.07% |
| 2017 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
| कंपनी | स्टॉक मूल्य | परिवर्तन 1व% | देश |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $765.49 | 8.80% |
CH
|
